Are these 2 impressive ASX shares buys for 2022?

ELMO Software is one of the potential options for 2022.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The next year is almost here. There are some impressive ASX shares to consider for 2022 which experts have rated as buys.

Businesses which are growing quickly have the ability to achieve attractive compound growth over a number of years.

a woman stares ahead with a serious expression on her face while half of her face is covered by computer coding, indicative of artificial intelligence and machine learning technology.

Image source: Getty Images

Bubs Australia Ltd (ASX: BUB)

Bubs is a leading goat milk infant formula business, but the Bubs share price has dropped by 24% this year.

The business is rated as a buy by the broker Citi, with a price target of $0.58. That suggests a potential rise of the share price of just over 25% in the next year, if the broker is right.

Citi notes the recovery that Bubs is seeing, particularly when it comes to the daigou channel. The broker also thinks that the ASX share can also expand its addressable market.

Bubs gave investors an insight into potential performance in 2022 with its FY22 first quarter update. Total gross revenue nearly doubled to $18.5 million, whilst Bubs infant formula daigou sales increased 648% year on year.

The ASX share is also making progress internationally. For the first three months of FY22, international (excluding China) gross revenue increased 489% year on year, contributing 24% of quarterly sales. Export sales of Bubs infant formula to markets outside of China grew 154%.

Bubs has signalled its expanding global strategy by establishing entities in New Zealand, China and the USA.

Looking at the product categories, the infant nutrition portfolio – which has higher margins than the adult goat dairy portfolio – saw growth of 89%. The infant formula gross revenue grew 124% year on year and 64% quarter on quarter.

Bubs management say that they are confident on its vision to take Bubs to a global stage.

ELMO Software Ltd (ASX: ELO)

ELMO Software is a leading HR and payroll tech company. It has a substantial presence in both Australia and the UK.

It's currently rated as a buy by the broker Morgan Stanley with a price target of $7.80. This would be a rise of more than 50%, if the broker's prediction ends up being right.

ELMO Software is steadily adding more modules for its small and medium clients to utilise. This can increase revenue made from the client, and make the ELMO software even more valuable to the client (and make them more 'sticky').

The broker thinks the ASX share can benefit from a number of tailwinds, such as more companies utilising digital tools and software.

In the first three months of FY22, revenue increased 52% to $20.7 million and annualised recurring revenue (ARR) surged 61% to $88.5 million. Cash receipts went up 78% to $27.7 million whilst the business had $75.7 million of cash on hand. The company becoming cashflow neutral/positive could help investor thoughts on the business, according to the broker.

Extending ELMO's module suite, it recently launched 'Experiences' for improve employee engagement and 'COVIDsecure' for things like recording, monitoring and reporting COVID vaccination and test status.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended Elmo Software. The Motley Fool Australia owns and has recommended Elmo Software. The Motley Fool Australia has recommended BUBS AUST FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Excited couple celebrating success while looking at smartphone.
Broker Notes

Up 222% in a year, why this ASX energy share is forecast to more than double your money again

A leading broker forecasts more outsized gains to come from this rocketing ASX energy share. But why?

Read more »

A man holds his head in his hands after seeing bad news on his laptop screen.
Broker Notes

3 massively popular ASX 200 shares experts say to sell (inc. CBA)

Let's see why they are bearish on these names this week.

Read more »

Two workers working with a large copper coil in a factory.
Broker Notes

Should you buy this $8 billion ASX 200 copper stock amid surging global demand?

A leading analyst drills into the outlook for this $8 billion ASX copper miner.

Read more »

Woman holding gold bar and cheering.
Broker Notes

Up 84% since August, should you buy this $6 billion ASX 200 gold stock today?

A leading expert digs into the outlook for this surging ASX 200 gold stock.

Read more »

A man has a surprised and relieved expression on his face.
Broker Notes

Guess which ASX copper share could surge almost 150%

Bell Potter thinks this stock could be a good pick for investors with a high tolerance for risk.

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today.
Broker Notes

Forget CBA shares, Bell Potter says this ASX financial stock could deliver a 75% return

The broker sees potential for major upside and a generous return from this stock.

Read more »

Lion roaring in the wild, symbolising a rising Liontown share price.
Broker Notes

Up 117% in a year, should you still buy Liontown shares now?

A leading analyst delivers his verdict on the soaring Liontown share price.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Buy, hold, sell: Bapcor, Challenger, and DroneShield shares

Analysts have given their verdict on these shares this week. Are they bullish, bearish, or something in between?

Read more »